About
SERO AS is a Norwegian biotechnology company that focuses on developing, manufacturing, and marketing high-quality quality control (QC) materials for medical laboratories worldwide. Founded in 1963 by Professor Dr. med. Lorentz Eldjarn, SERO has built a strong reputation for innovation in producing control sera and QC products that ensure reliable laboratory test results. The company specializes in a wide range of QC materials that support various clinical laboratory tests, including immunoassays, clinical chemistry, and markers for lipids, hormones, proteins, and more. SERO operates an ISO 13485-certified facility near Oslo, Norway, which integrates research, production, and logistics to maintain stringent quality control throughout the product lifecycle. One of its notable products is Seronorm®, recognized as one of the first commercially available control sera. SERO serves medical laboratories and healthcare facilities globally, with a significant presence in markets such as Scandinavia, Germany, and Japan. The company emphasizes ethical values and corporate social responsibility in its operations, reflecting its commitment to quality and trust in laboratory diagnostics.
Technologies
Keywords
Company Information
-
Employees 48
-
Founded 1963
Location
44 Stasjonsveien, Billingstad, Akershus, Norway, 1396